Overcome poor solubility barriers with BioDuro' s expertise in Amorphous Solid Dispersion (ASD) technology. Accelerate your drug development by transforming challenging, low-solubility compounds into bioavailable candidates ready for preclinical and clinical success.

• Minimal API Requirements: Develop viable formulations using only milligram quantities of your compound
• Speed to Solution: Generate prototype ASD formulations in just 2-3 weeks
• End-to-End Expertise: Seamlessly progress from early feasibility to cGMP manufacturing
• Integrated Approach: Leverage predictive modeling and in vivo studies to de-risk formulation selection

Download the flyer to discover how we can enhance bioavailability and accelerate your drug development journey!